COLESTIPOL HCL 1GM TAB and DESONIDE 0. 05% CREAM - 762 TUCSON

The Department of Veterans Affairs Veterans Health Administration, through its Veterans Integrated Service Network 15 Consolidated Mail Outpatient Pharmacy (CMOP) in Leavenworth, Kansas, is conducting market research to identify qualified domestic sources for two pharmaceutical products: Colestipol HCL 1GM tablets and Desonide 0.05% cream. This is a sources sought notice for market research purposes only and does not constitute a formal solicitation or obligate the VA to award a contract. Interested vendors must demonstrate their capability to meet the requirements specified in the attached Statement of Requirements document and must submit responses that include company points of contact (name, phone, and email), SAM Unique ID Number, and a detailed capability statement. The evaluation will focus on vendors' ability to meet the stated pharmaceutical supply requirements and their status as qualified domestic sources. All responses must be submitted via email to Jennifer Coleman at Jennifer.Coleman4@va.gov by December 19, 2025, at 3:00 p.m. Central Time, with responses being archived for 60 days following submission.

This procurement opportunity is designated as a Total Small Business set-aside, restricting eligibility to small business concerns. No incumbent contractor or current supplier information is identified in this sources sought notice. The government has not disclosed specific award values, budget ranges, or quantity requirements for these pharmaceutical products in the available documentation. The NAICS code 325412 (Pharmaceutical Preparation Manufacturing) and Product Service Code 6505 (Drugs and Biologicals) classify this requirement within the pharmaceutical manufacturing sector. Interested small businesses should note that submission of a response to this sources sought notice does not guarantee consideration for a future formal solicitation and is intended solely to gather market intelligence regarding available sources and capabilities for these specific pharmaceutical items.